Evidence map›Paper›PMID 34377421›Full record

ArticleChemical science2021

Simple cubic self-assembly of PbS quantum dots by finely controlled ligand removal through gel permeation chromatography.

Jianjun Liu, Kazushi Enomoto, Kotaro Takeda, Daishi Inoue, Yong-Jin Pu

Abstract read
In one paragraph

Article in Chemical science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Jianjun LiuRIKEN Center for Emergent Matter Science (CEMS) Wako Saitama 351-0198 Japan yongjin.pu@riken.jp.
Kazushi EnomotoRIKEN Center for Emergent Matter Science (CEMS) Wako Saitama 351-0198 Japan yongjin.pu@riken.jp.ORCID https://orcid.org/0000-0002-5119-9043
Kotaro TakedaRIKEN Center for Emergent Matter Science (CEMS) Wako Saitama 351-0198 Japan yongjin.pu@riken.jp.
Daishi InoueRIKEN Center for Emergent Matter Science (CEMS) Wako Saitama 351-0198 Japan yongjin.pu@riken.jp.
Yong-Jin PuRIKEN Center for Emergent Matter Science (CEMS) Wako Saitama 351-0198 Japan yongjin.pu@riken.jp.ORCID https://orcid.org/0000-0003-3841-2417

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The geometry in self-assembled superlattices of colloidal quantum dots (QDs) strongly affects their optoelectronic properties and is thus of critical importance for applications in optoelectronic devices. Here, we achieve the selective control of the geometry of colloidal quasi-spherical PbS QDs in highly-ordered two and three dimensional superlattices: Disordered, simple cubic (sc), and face-centered cubic (fcc). Gel permeation chromatography (GPC), not based on size-exclusion effects, is developed to quantitatively and continuously control the ligand coverage of PbS QDs. The obtained QDs can retain their high stability and photoluminescence on account of the chemically soft removal of the ligands by GPC. With increasing ligand coverage, the geometry of the self-assembled superlattices by solution-casting of the GPC-processed PbS QDs changed from disordered, sc to fcc because of the finely controlled ligand coverage and anisotropy on QD surfaces. Importantly, the highly-ordered sc supercrystal usually displays unique superfluorescence and is expected to show high charge transporting properties, but it has not yet been achieved for colloidal quasi-spherical QDs. It is firstly accessible by fine-tuning the QD ligand density using the GPC method here. This selective formation of different geometric superlattices based on GPC promises applications of such colloidal quasi-spherical QDs in high-performance optoelectronic devices.

Identifiers

PMID34377421
PMCPMC8336479

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.